Chair of Otolaryngology, Head & Neck Surgery – Vanderbilt
The Vanderbilt / VUMC Department of Otolaryngology, Head & Neck Surgery (OHNS) seeks an extraordinary leader as successor to the role of (endowed) Chairperson of the department. The current nationally respected Chair, Ron Eavey, MD, is electively stepping down from his leadership role after a successful tenure of 12 years at Vanderbilt.
Vanderbilt University / VUMC are among the most preeminent, internationally recognized, research-based universities, medical schools, and academic medical centers in the US and its Otolaryngology department is ranked #5 in the nation in NIH funding.
The Chair of Otolaryngology, Head & Neck Surgery reports to the President and CEO, VUMC and Dean, VU School of Medicine.
KEY SELECTION CRITERIA: Certification (and ideally subspecialty certification) by the American Board of Otolaryngology Head & Neck Surgery (ABOHNS) or equivalent is a pre-requisite with:
- A distinguished academic career including a leadership role within a multifaceted academic pathology department.
- A strong commitment to continued diversification of the faculty and trainees of the department, especially regarding recruitment and retention of women and underrepresented minorities.
- A highly regarded basic, translational, and/or clinical research background, with track record of scholarly achievements, extramural funding and impactful peer-reviewed publications.
- Clinical achievement, scholarly accomplishments, leadership aptitude and experience commensurate with appointment to the faculty at the rank of Professor.
Vanderbilt University Medical Center is committed to principles of equal opportunity and affirmative action.
Please submit any nominations or a current Curriculum Vitae along with a supporting cover letter of interest to: anne.neubauer@amnhealthcare.com
To apply for this job email your details to anne.neubauer@amnhealthcare.com
Charles C. Della Santina, PhD MD is a Professor of Otolaryngology – Head & Neck Surgery and Biomedical Engineering at the Johns Hopkins University School of Medicine, where he directs the Johns Hopkins Cochlear Implant Center and the Johns Hopkins Vestibular NeuroEngineering Laboratory.
Andrew Griffith received his MD and PhD in Molecular Biophysics and Biochemistry from Yale University in 1992. He completed his general surgery internship and a residency in Otolaryngology-Head and Neck Surgery at the University of Michigan in 1998. He also completed a postdoctoral research fellowship in the Department of Human Genetics as part of his training at the University of Michigan. In 1998, he joined the Division of Intramural Research (DIR) in the National Institute on Deafness and Other Communication Disorders (NIDCD). He served as a senior investigator, the chief of the Molecular Biology and Genetics Section, the chief of the Otolaryngology Branch, and the director of the DIR, as well as the deputy director for Intramural Clinical Research across the NIH Intramural Research Program. His research program identifies and characterizes molecular and cellular mechanisms of normal and disordered hearing and balance in humans and mouse models. Two primary interests of his program have been hearing loss associated with enlargement of the vestibular aqueduct, and the function of TMC genes and proteins. The latter work lead to the discovery that the deafness gene product TMC1 is a component of the hair cell sensory transduction channel. Since July of 2020, he has served as the Senior Associate Dean of Research and a Professor of Otolaryngology and Physiology in the College of Medicine at the University of Tennessee Health Science Center.
Gwenaëlle S. G. Géléoc obtained a PhD in Sensory Neurobiology from the University of Sciences in Montpellier (France) in 1996. She performed part of her PhD training at the University of Sussex, UK where she characterized sensory transduction in vestibular hair cells and a performed a comparative study between vestibular and cochlear hair cells. Gwenaelle continued her training as an electrophysiologist at University College London studying outer hair cell motility and at Harvard Medical School studying modulation of mechanotransduction in vestibular hair cells. As an independent investigator at the University of Virginia, she expanded this work and characterized the developmental acquisition of sensory transduction in mouse vestibular hair cells, the developmental acquisition of voltage-sensitive conductances in vestibular hair cells and the tonotopic gradient in the acquisition of sensory transduction in the mouse cochlea. This work along with quantitative spatio-temporal studies performed on several hair cell mechanotransduction candidates lead her to TMC1 and 2 and long-term collaborations with Andrew Griffith and Jeff Holt. Dr. Géléoc is currently Assistant Professor of Otolaryngology, at Boston Children’s Hospital where she continues to study molecular players involved in the development and function of hair cells of the inner ear and develops new therapies for the treatment of deafness and balance, with a particular focus on Usher syndrome.
Jeff Holt earned a doctorate from the Department of Physiology at the University of Rochester in 1995 for his studies of inward rectifier potassium channels in saccular hair cells. He went on to a post-doctoral position in the Neurobiology Department at Harvard Medical School and the Howard Hughes Medical Institute, where he characterized sensory transduction and adaptation in hair cells and developed a viral vector system to transfect cultured hair cells. Dr. Holt’s first faculty position was in the Neuroscience Department at the University of Virginia. In 2011 the lab moved to Boston Children’s Hospital / Harvard Medical School. Dr. Holt is currently a Professor in the Departments of Otolaryngology and Neurology in the F.M. Kirby Neurobiology Center. Dr. Holt and his team have been studying sensory transduction in auditory and vestibular hair cells over the past 20 years, with particular focus on TMC1 and TMC2 over the past 12 years. This work lead to the discovery that TMC1 forms the hair cell transduction channel. His work also focuses on development gene therapy strategies for genetic hearing loss.
Comments are closed.